Login / Signup

Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.

Ahmed M ShamanBrendan SmythClare ArnottSuetonia C PalmerAnastasia S MihailidouMeg J JardineMartin P GallagherVlado PerkovicMin Jun
Published in: Clinical journal of the American Society of Nephrology : CJASN (2020)
BP-lowering agents significantly reduced systolic BP in patients undergoing maintenance dialysis. β-Blockers and aldosterone antagonists may confer larger reductions, although treatment with aldosterone antagonists may be limited by adverse events.
Keyphrases
  • patients undergoing
  • chronic kidney disease
  • end stage renal disease
  • angiotensin ii
  • blood pressure
  • heart failure
  • angiotensin converting enzyme
  • left ventricular
  • peritoneal dialysis
  • replacement therapy